Home / Categories
Community
|
An opportunity for all
Well-managed regeneration projects – in the socio-economic as well as built environment – can be beneficial for local stakeholders as well as business itself.
| ||
|
Rhetoric versus reality –
managing the Olympic ideal
All the talk surrounding the ethical and sustainability credentials of the London Olympics must now become action according to Leo Martin of GoodCorporation.
|
Be a brave business
Camila Batmanghelidjh, founder of the charity Kids Company, calls for companies to partner with organisations such as her own in order to help children and thereby build stronger communities.
|
|
|
What role for corporate
foundations?
Is the integration of corporate responsibility into business strategy changing the traditional role of corporate foundations?
|
Building a world
community
Can online networking inspire a global movement for social good? Tommy Hutchinson, founder of networking site i-genius, thinks so and tells Mienke Retief how.
|
|
|
Community News Round-Up
(Issue 94)
ICT and social enterprises are providing services for communities in the UK and abroad.
|
Meeting society’s needs
A daunting new series of challenges to social inclusion, far more serious than in the 1980s, demand urgent corporate action, argues David Grayson.
|
|
|
Education and Skills News
Round-Up (Issue 94)
Education reforms, re-employing the disabled and forming an ethnic minority task force are all on the education and skills agenda.
|
China Health Alliance
takes aim at TB, HIV/AIDS
The director of the Global Health Initiative describes how a new public-private partnership, the China Health Alliance, aims to curb the spread and impact of HIV/AIDS and TB in China.
|
|
|
Community News Round-up
(Issue 93)
Technology and philanthropy are being called on to help communities from the north of England to South Africa.
|
Health news round-up
(Issue 93)
From an increase in access to ARV treatment for HIV/AIDS sufferers, to combating the sale of counterfeit drugs, and even producing a drug that will never make any profit, Briefing rounds up what the pharmaceutical firms are doing.
|
|





